NXTC (NextCure Corp) Wutah pendapatan kuartal marang kuartal

Tandha merek nextcure.com (NXTC)

The development of NextCure, Inc. (NXTC) relies on the validation of new immune checkpoints and the success of NC318 trials. The relative change in quarterly revenue reflects the dynamics of these processes, with the indicator reaching 0.00. NextCure, Inc. (NXTC) is creating innovative methods for combating tumors via hidden targets while strictly adhering to environmental standards for biohazardous waste disposal in its laboratories.

NextCure Corporation (NXTC) - Owah-owahan pendapatan dibandhingake kuartal kepungkur saka 04.07.2022 nganti 20.11.2026

Rincian analitis perusahaan NextCure (NXTC)

- kuotasi saiki lan rata-rata prakiraan nilai:
Analisis dhasar perusahaan:NXTC - NextCure, Inc.
Produk sing diprodhuksi nextcure.com

For the biotech startup NextCure, Inc. (NXTC), which is developing the NC410 drug and a partnership with Eli Lilly, revenue is often irregular, making the analysis of income dynamics critically important. The current quarterly revenue growth rate of 0.00 reflects the percentage increase in sales compared to the same period last year, allowing investors to assess the company's commercial viability and the risk of capitalization stagnation before the release of final clinical data.

Perusahaan pesaing

IBRX - Wutah pendapatan kuartal marang kuartal|IMCR (immunocore.com) - Wutah dodolan kuartal marang kuartal|Janux Corp (JANX) - Wutah pendapatan kuartal marang kuartal|Tingkat wutah pendapatan sajrone kuartal Arcus Bio (RCUS)|Wutah dodolan triwulanan ZYME|TNGX - Owah-owahan pendapatan dibandhingake kuartal kepungkur|Wutah dodolan triwulanan IOVA (Iovance)|Owah-owahan dodolan kuartal marang kuartal IMTX|Wutah pendapatan triwulanan XNCR (Xencor)|Tambahing pendapatan triwulanan CMPX|replimune.com - Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal Lyell Pharma|Innate Pharma S.A. (IPHA) - Wutah pendapatan kuartal marang kuartal|Pyxis Oncology Inc. - Tambahing pendapatan triwulanan|CGEN (Compugen Limited) - Wutah pendapatan triwulanan|Wutah pendapatan triwulanan IO Biotech Inc|Wutah pendapatan kuartal marang kuartal Sutro Biopharma (STRO)|INKT: Dinamika pendapatan kuartal marang kuartal|Werewolf Therapeutics, Inc. - Wutah dodolan triwulanan|Immix (IMMX) - Tingkat wutah pendapatan sajrone kuartal|ALX Oncology Holdings Inc. - Wutah pendapatan triwulanan|CUE - Wutah pendapatan triwulanan|PDSB: Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal Sonnet BioTherapeutics Holdings Inc. (SONN)|MAIA (MAIABiotech.com) - Wutah pendapatan triwulanan|Wutah dodolan triwulanan Liminatus Pharma (LIMN)|Wutah pendapatan triwulanan LVTX|LPTX: Dinamika pendapatan kuartal marang kuartal|Wutah pendapatan kuartal marang kuartal intensitytherapeutics.com INTS|Sensei Bio (SNSE) - Tingkat wutah pendapatan sajrone kuartal|TOVX: Wutah dodolan triwulanan|Gritstone bio - Owah-owahan dodolan kuartal marang kuartal|Kineta Bio (KA) - Wutah pendapatan kuartal marang kuartal|NexImmune Inc (NEXI) - Wutah pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal Turnstone Biologics Corp.|Wutah dodolan kuartal marang kuartal VCNX (Vaccinex, Inc.)|Wutah dodolan triwulanan HARP (Harpoon Tx)